TherapeuticsMD
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. TherapeuticsMD's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 98% to $1,302,000. The net income dropped to -$10,278,000 and profit margin reached -789%. Total operating expenses were $9,825,000.
Profit Margin
| 2014 | 15.02M | -54.21M | -360.82% |
|---|---|---|---|
| 2015 | 20.14M | -85.07M | -422.37% |
| 2016 | 19.35M | -89.87M | -464.32% |
| 2017 | 16.77M | -76.92M | -458.5% |
| 2018 | 16.09M | -132.61M | -823.74% |
| 2019 | 49.64M | -196.02M | -394.84% |
| 2020 | 64.87M | -212.70M | -327.88% |
| 2021 | 86.95M | -205.60M | -236.46% |
| 2022 | 69.96M | 111.99M | 160.08% |
| 2023 | 1.30M | -10.27M | -789.4% |
TXMD Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.30M | 69.96M | 86.95M | 64.87M | 49.64M | 16.09M | 16.77M | 19.35M | 20.14M | 15.02M |
Cost of revenue | 0 | 1.39M | 18.83M | 15.97M | 6.33M | 2.73M | 2.63M | 4.18M | 4.50M | 3.67M |
Gross profit | 1.30M | 68.56M | 68.11M | 48.89M | 43.31M | 13.36M | 14.14M | 15.17M | 15.63M | 11.35M |
Operating exp. | ||||||||||
Research and development | 0 | 0 | 7.08M | 10.43M | 19.79M | 27.29M | 33.85M | 53.94M | 72.04M | 43.21M |
Selling and marketing | 0 | 0 | 108.19M | 117.05M | 114.23M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 9.82M | 57.90M | 207.88M | 204.43M | 194.51M | 143.58M | 91.76M | 105.42M | 100.82M | 65.39M |
Operating income | -8.52M | 20.13M | -139.77M | -155.54M | -151.20M | -130.22M | -77.62M | -90.25M | -85.19M | -54.04M |
Other income (expenses), net | 781K | -19.06M | -32.64M | -27.98M | -24.93M | 2.28M | 703.33K | 367.31K | 113.16K | -176.14K |
Income before tax | -7.74M | 1.07M | -172.41M | -183.52M | -176.14M | -132.61M | -76.92M | -89.87M | -85.07M | -54.21M |
Income tax expense | 43K | -91.86M | 33.18M | 29.17M | 19.88M | 2.28M | -7.69K | 367.31K | -17.44K | 306.59K |
Net income | -10.27M | 111.99M | -205.60M | -212.70M | -196.02M | -132.61M | -76.92M | -89.87M | -85.07M | -54.21M |
Earnings per share | ||||||||||
Basic EPS | -0.55 | -10.35 | -25.83 | -38.58 | -39.79 | -29.47 | -18.71 | -22.92 | -24.56 | -18.11 |
Diluted EPS | -0.74 | -10.35 | -25.83 | -38.58 | -39.79 | -29.47 | -18.71 | -22.92 | -24.56 | -18.11 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |